The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4δ2, is not - 01/09/11
, Jung-Su Chang a, Jim F. Huggett a, Louise U. Kim a, Margaret A. Johnson b, Alimuddin Zumla a, Graham A.W. Rook a
Corresponding author. Centre for Infectious Diseases and International Health, UCL and Royal Free Medical School, London, UK. Tel.: +442076799354; fax: +442075314442.Summary |
The prototype Th2 cytokine IL-4, and its competitive antagonist IL-4δ2, may be important determinants of outcome in human tuberculosis (TB). However, there are no data on how gene expression of these cytokines is regulated.
To evaluate this the stability of IL-4 and IL-4δ2 mRNA after the addition of actinomycin-D, was evaluated in whole blood from subjects with pulmonary TB and uninfected healthy volunteers.
The Th2/Th1 (IL-4/IFN-γ) mRNA ratio in unstimulated cells in whole blood was significantly greater in TB subjects than in controls (p<0.05). The mRNA half-life of the agonist (IL-4), but not the antagonist (IL-4δ2), was significantly prolonged in subjects with TB compared to healthy volunteers (
5-fold, p=0.0016), and the IL-4/IL-4δ2 ratio was higher in TB patients compared to controls (p<0.05).
The differential stability of the Th2 agonist, IL-4, compared to the antagonist IL-4δ2, represents a hitherto undescribed post-transcriptional regulatory mechanism that may modulate the polarisation of Th1/Th2 responses in human TB.
Le texte complet de cet article est disponible en PDF.Keywords : IL-4, IL-4δ2, Human, Half-life, Tuberculosis, mRNA
Plan
Vol 87 - N° 3
P. 237-241 - mai 2007 Retour au numéro
Article précédent
- Unusual features of the cell cycle in mycobacteria: Polar-restricted growth and the snapping-model of cell division
- Niren R. Thanky, Douglas B. Young, Brian D. Robertson
- In silico analysis and characterization of GntR family of regulators from Mycobacterium tuberculosis
- Vaibhav Vindal, Sarita Ranjan, Akash Ranjan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?